The FDA has approved the Janus kinase inhibitor upadacitinib for the treatment of giant cell arteritis in adults, the first ...

The approval was based on data from the randomized, double-blind, placebo-controlled phase 3 SELECT-GCA trial.

AbbVie today announced the U.S. Food and Drug Administration (FDA) has approved RINVOQ® (upadacitinib), 15 mg, once daily, for the treatment of adults with giant cell arteritis (GCA).1 This comes ...

In closing, I urge all our readers to read or revisit Carl Sagan’s final book, The Demon-Haunted World: Science as a Candle in the Dark. It is one of my all-time favorite reads, which I first ...

Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in ...

Following up on last year’s massive spring six-day book sale, Amazon has announced it will hold a similar event from April 23 to 28. Plugged as “Amazon’s only dedicated book deals event of ...

“After that, it became my passion to help people recognize narcissistic abuse and how to help themselves heal from that exposure,” said Nunnery, who in March celebrated the release of her new book ...

Health care giant Johnson & Johnson is one of the most ... very long time," but his comprehensively reported and researched book goes much further. Harris takes a deeper dive in looking at Johnson ...

This book cover image released by Random House shows "No More Tears: The Dark Secrets of Johnson & Johnson" by Gardiner Harris. (Random House via AP) Health care giant Johnson & Johnson is one of the ...

Health care giant Johnson & Johnson is one of the most ... killed seven people is held up in business schools as a model. Book Review: How would Joan Didion feel about her therapy session notes ...

Health care giant Johnson & Johnson is one of the most ... seven people is held up in business schools as a model. 34 new books in our spring 2025 preview to add to your TBR pile For romance ...

AbbVie has won expanded European approval of its blockbuster autoimmune drug Rinvoq for the treatment of adults with giant cell arteritis. AbbVie on Tuesday said the European Commission's nod ...